SHANNON NIEBRUGGE: Open Payments
NPI 1831825280 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 45 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $623 · 2025 $1,054
Food & beverage: $923Education: $131
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $183 |
| ABBVIE INC. | 2 | $115 |
| Daiichi Sankyo Inc. | 3 | $84 |
| PFIZER INC. | 3 | $75 |
| ARRAY BIOPHARMA INC | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Janssen Biotech, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $46 |
Products named: VENCLEXTA, Fabhalta, IBRANCE, INJECTAFER, OPDIVO, PLUVICTO, Enhertu, VERZENIO.
Industry payments across IL — which companies pay providers there.
